5-N-Propyluracil, 95.0%, 5g

3,4,5,6-tetrakis(3,6-di-t-Butylcarbazol-9-yl)- 1,2-dicyanobenzene, 97%, 100mg

2,8-Dimethyl-quinoline-4-carboxylic acid, 95.0%, 2.5g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one, 95.0%, 250mg

Fmoc-D-Val-OH, 99.00%, 5g

(3R)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid, 97%, 10g

O-(Benzotriazol-1-yl)-N,N,N',N'-bis(pentamethylene)uronium Hexafluorophosphate>98.0%(HPLC)5g

TRIS(2-THIENYL)PHOSPHINE, 95.0%, 10g

4-Bromo-2-methylbenzoic acid, 97.0%, 75g

Colonna capillare per GC ROTI®Cap-5, 10 m, 0.53 mm, 0.50 µm, 1 Pezzo(i)

4-Methyl-3-(methylsulfonyl)benzoic acid, 98%, 1g

3-CHLORO-1,1-DIPHENYLPROPAN-2-ONE, 95.0%, 2g

pyridazine-3-thiol, 95.0%, 1g